← Back to Browse
ProductDiagnostic Tests

Cardiac Risk Assessment Platform

Bundang, South Korea

Platform that evaluates ECG data to identify critical cardiac conditions including shock, respiratory distress, cardiac arrest, and severe electrolyte imbalances requiring emergency intervention. Delivers analysis results in real-time for emergency transport scenarios.

Manufactured by

ARPI, Inc

Bundang, South Korea

ARPI, Inc. is a South Korean medical device company that develops AI-powered ECG analysis software for healthcare applications. The company's flagship product, ECG Buddy, is a Class II medical device approved by MFDS that analyzes 12-lead ECG images to identify 11 major cardiac rhythms and provides risk assessment for 10 digital biomarkers. The software automatically detects ECG regions and delivers rapid interpretation for emergency and clinical settings.

View profile & products →

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

Top sourcing countries

1China
1 relevant product
2United States
1 relevant product

See the full supplier coverage for this product

Get free access to all relevant manufacturers, sourcing countries, and product alternatives.

Get Free Access →

Free for medical industry professionals.

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

2 of 2 closest product alternatives

2 products

© 2026 Suplivia · Home · Browse Products